Trailing Twelve Months Sales Growth: Aptose Biosciences (APTO)

Graphic logo of aptose.com (APTO)

This chart of year-over-year revenue growth over the last 12 months illustrates the dynamics of Aptose Biosciences Inc. (APTO), where 0.00 serves as the base parameter value. Aptose Biosciences Inc. develops targeted therapies for hemoblastoses, leveraging inhibitor patents to ensure long-term profitability. These developments are based on the creation of next-generation small molecules, and the company is currently accelerating trials of oral agents to combat leukemia.

Aptose Biosciences - APTO Sales Growth YoY (Last Twelve Months) (period 02/11/2024 - 02/20/2024)

Aptose Biosciences (APTO) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company valuation:aptose.com
Signature product of aptose.com

This indicator measures the percentage change in revenue over a rolling year, neutralizing seasonality by comparing the current twelve-month period with the equivalent prior period. By analyzing the relative year-over-year (LTM) revenue dynamics, an investor assesses the cash flow stability of Aptose Biosciences Inc. (APTO), which is critical when implementing joint clinical projects to develop kinase inhibitors in partnership with global biopharma behemoths.